Literature DB >> 8478110

Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.

H M Surcel1, H Syrjälä, M Leinonen, P Saikku, E Herva.   

Abstract

The purpose of the present study was to analyze Chlamydia pneumoniae-induced, antigen-specific, cell-mediated immunity. Peripheral blood mononuclear cells of four persons infected with C. pneumoniae Kajaani 6 and 17 healthy volunteers were stimulated with antigen composed of whole elementary bodies of C. pneumoniae Kajaani 6 (CP-Ag). Definitive antigen-specific lymphoproliferation (LP) responses were developed after recent infection. The LP responses of healthy people to CP-Ag varied considerably. There was no clear correlation between LP responses to CP-Ag and those to an antigen prepared from Chlamydia trachomatis serotype L2 (r > or = 0.50, P < 0.1). A larger study is required to demonstrate whether the LP responses to CP-Ag can be used for the diagnosis of C. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478110      PMCID: PMC280821          DOI: 10.1128/iai.61.5.2196-2199.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

4.  Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatis.

Authors:  E Qvigstad; S Digranes; E Thorsby
Journal:  Scand J Immunol       Date:  1983-10       Impact factor: 3.487

5.  Characterization of Chlamydia trachomatis serotypes by human T-lymphocyte clones.

Authors:  E Qvigstad; K Skaug; H Hirschberg
Journal:  Scand J Immunol       Date:  1985-03       Impact factor: 3.487

6.  Proliferative human T cell responses to Chlamydia trachomatis in vitro.

Authors:  E Qvigstad; K Skaug; E Thorsby
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-06

7.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  9 in total

1.  Cell-mediated immune response during primary Chlamydia pneumoniae infection.

Authors:  S Halme; J Latvala; R Karttunen; I Palatsi; P Saikku; H M Surcel
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.

Authors:  Robert M Wadowsky; Elias A Castilla; Stella Laus; Anita Kozy; Robert W Atchison; Lawrence A Kingsley; Joel I Ward; David P Greenberg
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line.

Authors:  M Heinemann; M Susa; U Simnacher; R Marre; A Essig
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.

Authors:  J T Summersgill; N N Sahney; C A Gaydos; T C Quinn; J A Ramirez
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

5.  Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.

Authors:  R Clancy; Z Ren; G Pang; P Fletcher; C D'Este
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 6.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women.

Authors:  A Kinnunen; H-M Surcel; M Halttunen; A Tiitinen; R P Morrison; S G Morrison; P Koskela; M Lehtinen; J Paavonen
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

8.  Atypical respiratory pathogens.

Authors:  Pekka Saikku
Journal:  Clin Microbiol Infect       Date:  1997-02       Impact factor: 8.067

9.  Immunology of non-trachomatis chlamydial infection.

Authors:  M Poussin; V Fuentes; J Orfila
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.